• E-mail
  • Save
29 Stories on Impotence
Search this topic

10 years of Viagra: What the blue pill couldn't cure

Before middle-aged men started singing "Viva Viagra" in TV ads, before former Sen. Bob Dole appeared in its commercials in the '90s, before the blue pill with a funny name entered the public lexicon, impotence was hush-hush.

Five symptoms men shouldn't ignore

Ask doctors if their male patients ignore big and obvious health symptoms, and they'll respond with laughter -- huge peals and guffaws.

CNNMoney: Erectile dysfunction drugs may harm hearing

Men taking any of the three erectile dysfunction drugs - Viagra, Levitra or Cialis - or the blood pressure medication Revatio may be at increased risk for sudden hearing loss, prompting Food and Drug Administration officials to require label changes by the manufacturer.

Impotence drugs may increase risk for sudden hearing loss

Men taking any of three erectile dysfunction drugs -- Viagra, Levitra or Cialis -- may be at increased risk for sudden hearing loss, prompting Food and Drug Administration officials to require label changes for the medications.

Viagra boosts feel-good 'love' hormone

Impotence drugs such as Viagra may do more than help men physically have sex -- they may also boost levels of a hormone linked with feelings of love, U.S. researchers reported Thursday.

This week in the medical journals

Drug safety questioned

CNNMoney: Lilly's sex drug sales jump in 2005

Sales for Lilly's anti-impotence drug grew dramatically in 2005, but Cialis' future and that of competing sexual dysfunction drugs remains uncertain.

CNNMoney: Sex dysfunction drugs: Nowhere to grow?

The glory days of sexual dysfunction drugs may have come and gone

'Robots helped treat my prostate cancer'

John Fox was diagnosed with prostate cancer two years ago. After researching different treatments on the Internet, he elected to have laproscopic radical prostatectomy surgery -- a procedure less intrusive than traditional treatments. Here is his story:

CNNMoney: Biotech soars on nasal spray aphrodisiac

Shares in Palatin Technologies Inc. jumped over 20 percent Tuesday after the biotech company's new nasal spray aphrodisiac appeared in TV news and magazine reports.

Advertisement
Quick Job Search :
keyword(s):
enter city: